Sign inJoin waitlistJoin the waitlist

William Read

Physician · Emory University School of Medicine

Credentials: · · · ·

History

Emory University School of Medicine
Present

Medical Oncology
1999–2001
Internal Medicine
1996–1999
Univ of Nebraska Coll of Med
1992–1996

Research

Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial
JAMA · 2017 · 2,133 citations
Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database
Journal of Clinical Oncology · 2006 · 1,522 citations
Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre,…
The Lancet Oncology · 2017 · 258 citations

Ramaswamy Govindan
12 papers
HM
Howard McLeod
5 papers
BT
Brian Van Tine
4 papers
Felicia Williams
4 papers
Gary Schwartz
3 papers
Jay Piccirillo
3 papers
MB
Maria Baggstrom
3 papers
Nathan Page
3 papers · 3 as a resident
PF
Paula Fracasso
3 papers
Richard Riedel
3 papers
RT
Ryan Tierney
3 papers · 1 as a resident
SC
Sant Chawla
3 papers

Grants

General Clinical Research Center
National Center for Research Resources · M01
Project lead · $698 · University of California, San Diego
2006–2007

Clinical trials

Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma
Principal investigator · Recruiting · Phase 1, Phase 2
Emory University
2021–2025
A Study of Subcutaneous Bevacizumab in Relapsed / Progressive Glioblastoma
Principal investigator · Completed · Phase 2
Emory University
2014–2018
A Study of Lapatinib in Combination With Everolimus in Patients With Advanced, Triple Negative Breast Cancer
Principal investigator · Terminated · Phase 2
Emory University
2010–2014
Gefitinib and PEG-Interferon Alfa-2a in Treating Patients With Unresectable or Metastatic Skin Cancer
Study chair · Unknown · Phase 1, Phase 2
University of California, San Diego
2006